The Cooper Companies (COO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
24 Feb, 2026Executive summary
Annual meeting scheduled for April 7, 2026, at the company’s headquarters in San Ramon, California.
Shareholders are invited to vote on key proposals, including director elections, auditor ratification, and executive compensation.
Voting matters and shareholder proposals
Election of nine directors, with each nominee recommended for approval by the board.
Ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending October 31, 2026.
Advisory vote to approve the compensation of named executive officers.
Board of directors and corporate governance
Board recommends all director nominees for election.
Director slate includes Colleen E. Jay, Barbara A. Carbone, Lawrence E. Kurzius, Cynthia L. Lucchese, Teresa S. Madden, Maria Rivas, M.D., Walter M Rosebrough, Jr., Robert S. Weiss, and Albert G. White III.
Latest events from The Cooper Companies
- Record Q2 revenue and non-GAAP EPS growth, but litigation charge drove a GAAP net loss.COO
Q2 2026 - Q1 2026 saw 6% revenue growth, raised FY26 guidance, and strong cash flow and share buybacks.COO
Q1 2026 - Strong 2025 results, expanded buybacks, and robust governance set the stage for 2026 growth.COO
Proxy Filing - Record revenues, margin expansion, and strong 2025 growth outlook amid ongoing investments.COO
Q4 2024 - Double-digit growth, margin gains, and strong guidance highlight sustained momentum.COO
2024 Wells Fargo Healthcare Conference - Q3 revenue up 8% to $1.0B, net income up 23%, and FY24 guidance raised on strong segment growth.COO
Q3 2024 - Contact lens growth accelerates on capacity gains and premium demand, with margins set to improve.COO
Jefferies Global Healthcare Conference - FY24 guidance raised as growth, innovation, and market leadership drive a positive outlook.COO
The 44th Annual William Blair Growth Stock Conference - Q2 revenue up 6% and non-GAAP EPS up 14%, with raised FY25 guidance amid softer markets.COO
Q2 2025